dextrothyroxine has been researched along with Rosacea in 77 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.30) | 18.2507 |
2000's | 3 (3.90) | 29.6817 |
2010's | 48 (62.34) | 24.3611 |
2020's | 25 (32.47) | 2.80 |
Authors | Studies |
---|---|
Cribier, B | 1 |
Hsu, CK; Huang, HP; Lee, JY | 2 |
Balogh, EA; Cook, MK; Feldman, SR; Kelly, KA; Perche, PO; Richardson, I; Singh, R | 2 |
Fridman, A; Fridman, G; Friedman, PC; Gill, M; Malik, S | 1 |
Bernhard, D; Clanner-Engelshofen, BM; Dargatz, S; Flaig, MJ; Gieler, U; Kinberger, M; Klövekorn, W; Kuna, AC; Läuchli, S; Lehmann, P; Nast, A; Pleyer, U; Reinholz, M; Schaller, M; Schöfer, H; Schwennesen, T; Steinhoff, M; Werner, RN; Zierhut, M | 1 |
Bashur, R; Fehrenbacher, B; Kurup, N; Riel, S; Schaller, M; Schnidar, H | 1 |
Flowers, RH; Vittitow, SL; Wilson, BB | 1 |
Huang, YC; Tsai, J; Wang, HH; Yeh, MC | 1 |
Cook, MK; Feldman, SR; Kelly, KA; Perche, PO; Richardson, I; Singh, R | 1 |
Balogh, EA; Cook, MK; Feldman, SR; Kelly, KA; Perche, PO; Richardson, IM; Singh, R | 1 |
Ansorge, C; Technau-Hafsi, K | 1 |
Cozzani, E; Merlo, G; Parodi, A; Trave, I | 1 |
Fritsch, P; Kolber, MR; Korownyk, C | 1 |
Bisbee, E; Loyd, A; Rudnick, E | 1 |
Husein-ElAhmed, H; Steinhoff, M | 1 |
Atef Khalifa, M; Hassan, AM; Osman, M; Shokeir, HA | 1 |
de Jong, EMGJ; Driessen, RJB; Logger, JGM; Nguyen, KP; Peppelman, M; van Erp, PEJ | 1 |
Deuter, CM; Doycheva, D; Schaller, M; Sobolewska, B; Zierhut, M | 1 |
Aguado García, Á; Garabito Solovera, E; Garayar Cantero, M; Manchado López, P; Ruiz Sánchez, D; Valtueña, J | 1 |
de Jong, EMGJ; Driessen, RJB; Logger, JGM; van Erp, PEJ | 1 |
Bustos, R; Castro, A; Cortes, A; Fuentes, E; McNab, ME; Wortsman, X | 1 |
Baldwin, H; Harper, JC; Stein Gold, L | 1 |
Chibnall, RJ; Compton, LA; Hedberg, ML | 1 |
Dall'Oglio, F; Lacarrubba, F; Micali, G | 1 |
Cline, A; Gomolin, T; Pereira, F | 1 |
Hernández-Martín, Á | 1 |
Aghazadeh, N; Moeineddin, F; Zargari, O | 1 |
Chong, AH; Maor, D | 1 |
Jackson, JM; Kerrouche, N; Schäfer, G; Schaller, M; Tan, J; Webster, G | 1 |
Belge, K; Borelli, C; Braunsdorf, C; Gonser, L; Nordin, R; Schaller, M; Scheu, A | 1 |
Ciccarese, G; Drago, F; Parodi, A; Rebora, A | 1 |
Gold, LS; Gooderham, M; Johnson, S; Kerrouche, N; Lain, E; Lynde, C; Papp, K | 1 |
Alinia, H; Feldman, SR; Fleischer, A; McGregor, SP; Snyder, A; Tuchayi, SM | 1 |
Pietschke, K; Schaller, M | 1 |
Feldman, SR; Sahni, DR; Taylor, SL | 1 |
Hellen, R; Ní Raghallaigh, S | 1 |
Ambroziak, M; Chavda, R; Del Rosso, J; Dirschka, T; Gooderham, M; Havlickova, B; Jackson, JM; Johnson, S; Kemény, L; Kerrouche, N; Lynde, C; Remenyik, E; Schaller, M; Weglowska, J | 1 |
Chitanava, L; Katsitadze, A; Tsiskarishvili, NI; Tsiskarishvili, NV; Tsiskarishvili, T | 1 |
Layton, A; Thiboutot, D | 1 |
Brown, M; Clement, A; Colmenero, I; Hernández-Martín, A; Torrelo, A | 1 |
Sarnoff, DS | 1 |
Appell, M; Draelos, Z; Fleischer, A; Fowler, J; Jacovella, J; Kircik, L; Liu, H; Lynde, C; Stein, L; Steinhoff, M; Tan, J | 1 |
Feldman, SR; Moustafa, FA; Sandoval, LF | 1 |
Berth-Jones, J; Jacovella, J; Ortonne, JP; Peirone, MH; Roszkiewicz, J; Ruzicka, T; Taieb, A | 1 |
Abokwidir, M; Fleischer, AB | 2 |
Appell, M; Draelos, Z; Fleischer, A; Fowler, J; Jackson, JM; Jacovella, J; Kircik, L; Liu, H; Lynde, C; Stein Gold, L; Steinhoff, M; Sugarman, J; Tan, J | 1 |
Gallo, RL; Hata, TR; Two, AM; Wu, W | 1 |
Carter, B; Charland, L; Fedorowicz, Z; van der Linden, MM; van Zuuren, EJ | 1 |
Ali, ST; Alinia, H; Feldman, SR | 1 |
Deeks, ED | 1 |
Draelos, ZD; Gold, LM | 1 |
Barańska-Rybak, W; Berth-Jones, J; Briantais, P; Jacovella, J; Khemis, A; Passeron, T; Ruzicka, T; Schauber, J; Taieb, A | 1 |
Del Rosso, JQ; Kircik, LH; Layton, AM; Schauber, J | 1 |
Berth-Jones, J; Huang, MY; Jacovella, J; Passeron, T; Ruzicka, T; Taieb, A; Wertheimer, A | 1 |
Asai, Y; Baibergenova, A; Barankin, B; Cochrane, CL; Humphrey, S; Lynde, CW; Marcoux, D; Poulin, Y; Rivers, JK; Sapijaszko, M; Sibbald, RG; Tan, J; Toole, J; Ulmer, M; Zip, C | 1 |
Bertranou, E; Dansk, V; Feldman, SR; Stein Gold, L; Taieb, A | 1 |
Helfrich, YR; Maier, LM | 1 |
Keri, J | 1 |
Hacini-Rachinel, F; Schäfer, G; Steinhoff, M; Vocanson, M; Voegel, JJ | 1 |
Fowler, JF | 1 |
Landa Gundin, N; Mendieta Eckert, M | 1 |
Gazewood, JD; Johnson, K | 1 |
Hartmann, D; Reinholz, M; Ruini, C; Ruzicka, T; Sattler, E; von Braunmühl, T | 1 |
Ezmerli, M; Hartmann, D; Käser, S; Reinholz, M; Ruini, C; Ruzicka, T; von Braunmühl, T | 1 |
Gerlero, P; Hernández-Martín, Á; Noguera-Morel, L; Torrelo, A | 1 |
Fallen, RS; Gooderham, M | 1 |
Aquilina, C; Sire, S; Viraben, R | 1 |
Rufli, T | 1 |
Allen, KJ; Billings, SD; Davis, CL; Mousdicas, N | 1 |
Binder, M; Forstinger, C; Kittler, H | 1 |
21 review(s) available for dextrothyroxine and Rosacea
Article | Year |
---|---|
Rosacea: Treatment targets based on new physiopathology data.
Topics: Animals; Antiparasitic Agents; Humans; Isotretinoin; Ivermectin; Mite Infestations; Mites; Rosacea; Sebaceous Glands | 2022 |
Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta-analysis.
Topics: Administration, Cutaneous; Dermatologic Agents; Humans; Ivermectin; Quality of Life; Rosacea; Treatment Outcome | 2020 |
Symptomatic vulvar demodicosis: A case report and review of the literature.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Antiparasitic Agents; Antiprotozoal Agents; Blepharitis; Drug Therapy, Combination; Erythema; Facial Dermatoses; Female; Folliculitis; Humans; Ivermectin; Metronidazole; Mite Infestations; Mites; Rosacea; Skin Diseases; Treatment Outcome; Vulva | 2020 |
Treatment of rosacea during pregnancy.
Topics: Adult; Algorithms; Animals; Anti-Bacterial Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Isotretinoin; Ivermectin; Metronidazole; Mice; Minocycline; Phototherapy; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rosacea; Tetracyclines; Treatment Outcome | 2021 |
Clinical applications of topical ivermectin in dermatology.
Topics: Administration, Cutaneous; Antiparasitic Agents; Humans; Ivermectin; Lice Infestations; Mite Infestations; Myiasis; Rosacea; Scabies; Scalp Dermatoses | 2016 |
A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
Topics: Administration, Cutaneous; Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2018 |
Ivermectin 1% (CD5024) for the treatment of rosacea.
Topics: Administration, Topical; Antiparasitic Agents; Clinical Trials as Topic; Half-Life; Humans; Ivermectin; Rosacea | 2018 |
Rosacea First-choice treatments.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2017 |
Emerging therapies in rosacea.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Cytokines; Doxycycline; Erythema; Humans; Ivermectin; Mite Infestations; Permethrin; Rosacea | 2013 |
Therapeutic update on Rosacea.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Anti-Bacterial Agents; Dermatologic Agents; Humans; Ivermectin; Laser Therapy; Life Style; Rosacea | 2014 |
Rosacea: new and emerging treatments.
Topics: Administration, Cutaneous; Brimonidine Tartrate; Dermatologic Agents; Drug Design; Humans; Ivermectin; Oxymetazoline; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea | 2014 |
Rosacea: part II. Topical and systemic therapies in the treatment of rosacea.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Calcineurin Inhibitors; Dicarboxylic Acids; Humans; Ivermectin; Mast Cells; Patient Education as Topic; Retinoids; Rosacea; Serine Proteinase Inhibitors; Tetracyclines | 2015 |
Interventions for rosacea.
Topics: Anti-Infective Agents; Brimonidine Tartrate; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ophthalmic Solutions; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2015 |
The treatment of rosacea with topical ivermectin.
Topics: Acaricides; Administration, Topical; Animals; Clinical Trials as Topic; Humans; Ivermectin; Mites; Rosacea; Treatment Outcome | 2015 |
Ivermectin: A Review in Rosacea.
Topics: Administration, Cutaneous; Anti-Infective Agents; Antiparasitic Agents; Drug Administration Schedule; Humans; Ivermectin; Metronidazole; Rosacea; Time Factors | 2015 |
New and Emerging Treatments for Rosacea.
Topics: Administration, Topical; Brimonidine Tartrate; Clinical Trials, Phase III as Topic; Dermatologic Agents; Dicarboxylic Acids; Drug Approval; Female; Follow-Up Studies; Forecasting; Humans; Ivermectin; Male; Oxymetazoline; Patient Satisfaction; Rosacea; Severity of Illness Index; Treatment Outcome; United States; United States Food and Drug Administration | 2015 |
Canadian Clinical Practice Guidelines for Rosacea.
Topics: Anti-Infective Agents; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Eye Diseases; Humans; Intense Pulsed Light Therapy; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Outliers, DRG; Practice Guidelines as Topic; Rosacea; Tetracycline | 2016 |
Topical and oral therapeutic approach to rosacea.
Topics: Administration, Cutaneous; Administration, Oral; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Evidence-Based Medicine; Humans; Ivermectin; Metronidazole; Rosacea; Treatment Outcome | 2016 |
What's new in acne and rosacea?
Topics: Acne Vulgaris; Brimonidine Tartrate; Dapsone; Dermatologic Agents; Dermatology; Gels; Humans; Isotretinoin; Ivermectin; Rosacea; Skin Cream; Treatment Outcome | 2016 |
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.
Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Delayed-Action Preparations; Doxycycline; Drug Therapy, Combination; Humans; Inflammation; Ivermectin; Rosacea; Treatment Outcome | 2016 |
Ivermectin-responsive Demodex infestation during human immunodeficiency virus infection. A case report and literature review.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Diagnosis, Differential; Drug Administration Schedule; Follow-Up Studies; HIV Seropositivity; Humans; Ivermectin; Male; Middle Aged; Mite Infestations; Risk Assessment; Rosacea; Treatment Outcome | 2002 |
10 trial(s) available for dextrothyroxine and Rosacea
Article | Year |
---|---|
Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial.
Topics: Animals; Humans; Ivermectin; Metronidazole; Mites; Rosacea | 2022 |
Pulsed dye laser alone versus its combination with topical ivermectin 1% in treatment of Rosacea: a randomized comparative study.
Topics: Humans; Ivermectin; Lasers, Dye; Rosacea; Treatment Outcome | 2022 |
Color Doppler ultrasonographic evaluation of management of papulopustular rosacea.
Topics: Administration, Cutaneous; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Healthy Volunteers; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Rosacea; Skin; Treatment Outcome; Ultrasonography, Doppler, Color | 2021 |
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Humans; Ivermectin; Male; Middle Aged; Patient Satisfaction; Rosacea; Skin Cream; Treatment Outcome; Young Adult | 2017 |
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
Topics: Administration, Oral; Adult; Capsules; Delayed-Action Preparations; Doxycycline; Drug Therapy, Combination; Female; Humans; Ivermectin; Male; Patient Satisfaction; Placebos; Quality of Life; Rosacea; Severity of Illness Index; Skin Cream; Time Factors; Treatment Outcome | 2020 |
Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Double-Blind Method; Female; Humans; Ivermectin; Male; Middle Aged; Patient Satisfaction; Quality of Life; Rosacea; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ointments; Patient Satisfaction; Rosacea; Treatment Outcome; Young Adult | 2015 |
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Dermatologic Agents; Dicarboxylic Acids; Female; Gels; Humans; Ivermectin; Male; Middle Aged; Rosacea; Single-Blind Method; Skin Cream; Time Factors; Young Adult | 2014 |
Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.
Topics: Humans; Ivermectin; Metronidazole; Remission Induction; Rosacea | 2016 |
Ivermectin cream improves health-related quality of life in patients with rosacea: data from a randomized trial.
Topics: Adolescent; Adult; Aged; Dermatologic Agents; Humans; Ivermectin; Metronidazole; Middle Aged; Ointments; Quality of Life; Rosacea; Treatment Outcome; Young Adult | 2016 |
46 other study(ies) available for dextrothyroxine and Rosacea
Article | Year |
---|---|
Topical ivermectin-induced transient flare of rosacea as a host reaction to killed Demodex mites preventable by short-term use of topical corticosteroid.
Topics: Adrenal Cortex Hormones; Animals; Humans; Ivermectin; Mite Infestations; Mites; Rosacea | 2022 |
Greater rosacea severity correlates with greater adherence and improvement in a clinical study.
Topics: Humans; Ivermectin; Rosacea | 2023 |
Cold atmospheric plasma reduces demodex count on the face comparably to topical ivermectin, as measured by reflectance confocal microscopy.
Topics: Animals; Ivermectin; Microscopy, Confocal; Mite Infestations; Mites; Plasma Gases; Rosacea | 2022 |
S2k guideline: Rosacea.
Topics: Brimonidine Tartrate; Dermatologic Agents; Erythema; Humans; Ivermectin; Metronidazole; Rosacea | 2022 |
Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
Topics: Erythema; Humans; Ivermectin; Pilot Projects; Pruritus; Quality of Life; Rosacea; Smartphone; Technology | 2022 |
Patient perspectives on the use of topical equine ivermectin ("horse paste") for rosacea: a survey study.
Topics: Animals; Horses; Ivermectin; Rosacea; Surveys and Questionnaires | 2022 |
Perception of accountability decreases with age: observations from a clinical study of patients with rosacea.
Topics: Administration, Cutaneous; Humans; Ivermectin; Perception; Rosacea; Skin Cream | 2023 |
The Patient-Physician Relationship and Adherence: Observations From a Clinical Study.
Topics: Humans; Ivermectin; Medication Adherence; Patient Satisfaction; Physicians; Rosacea; Treatment Outcome | 2023 |
Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Humans; Ivermectin; Rosacea; Skin | 2023 |
[Granulomatous rosacea in a lung transplant recipient : A possible therapy option in a unique group of patients].
Topics: Aged; Animals; Humans; Immunocompromised Host; Insecticides; Ivermectin; Metronidazole; Mite Infestations; Rosacea; Transplant Recipients | 2020 |
Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Animals; Antiparasitic Agents; Female; Humans; Ivermectin; Male; Middle Aged; Mite Infestations; Mites; Retrospective Studies; Rosacea; Severity of Illness Index; Treatment Outcome | 2019 |
Topical treatments for rosacea.
Topics: Administration, Topical; Dicarboxylic Acids; Drug Costs; Humans; Ivermectin; Metronidazole; Patient Reported Outcome Measures; Rosacea | 2019 |
Crusted demodicosis in an immunocompetent patient.
Topics: Administration, Oral; Administration, Topical; Antiparasitic Agents; Facial Dermatoses; Humans; Immunocompetence; Ivermectin; Male; Middle Aged; Mite Infestations; Rosacea | 2019 |
Value of reflectance confocal microscopy for the monitoring of rosacea during treatment with topical ivermectin.
Topics: Animals; Humans; Inflammation; Ivermectin; Microscopy, Confocal; Mites; Rosacea | 2022 |
Efficacy of Topical Ivermectin for the Treatment of Cutaneous and Ocular Rosacea.
Topics: Administration, Ophthalmic; Adult; Aged; Antiparasitic Agents; Blepharitis; Conjunctivitis; Female; Humans; Ivermectin; Male; Meibomian Gland Dysfunction; Middle Aged; Pilot Projects; Retrospective Studies; Rosacea; Skin Cream; Treatment Outcome; Visual Acuity | 2021 |
Use of permethrin in the treatment of rosacea fulminans during pregnancy: One case report.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Ivermectin; Metronidazole; Permethrin; Pregnancy; Rosacea | 2020 |
Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatment.
Topics: Administration, Cutaneous; Erythema; Humans; Ivermectin; Photography; Retrospective Studies; Rosacea; Severity of Illness Index; Skin Cream; Treatment Outcome | 2020 |
Rationale for Use of Combination Therapy in Rosacea.
Topics: Administration, Cutaneous; Adrenergic alpha-Agonists; Adult; Aftercare; Anti-Inflammatory Agents; Color; Combined Modality Therapy; Dermatology; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Ivermectin; Laser Therapy; Male; Middle Aged; Patient Education as Topic; Practice Guidelines as Topic; Rosacea; Skin; Skin Pigmentation; Societies, Medical; Treatment Outcome; United States | 2020 |
Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol.
Topics: Carvedilol; Erythema; Humans; Ivermectin; Retrospective Studies; Rosacea | 2021 |
Erythema-directed digital photography and colorimeter scores correlate with rosacea erythema evaluation in patients under treatment with topical ivermectin.
Topics: Erythema; Humans; Ivermectin; Photography; Rosacea; Treatment Outcome | 2021 |
Oral Ivermectin to Treat Papulopustular Rosacea in a immunocompetent patient.
Topics: Administration, Oral; Adult; Humans; Immunocompetence; Ivermectin; Male; Rosacea | 2017 |
Rosacea.
Topics: Anti-Bacterial Agents; Brimonidine Tartrate; Diagnosis, Differential; Doxycycline; Humans; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Rosacea | 2017 |
Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.
Topics: Adult; Aged; Dermatologic Agents; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Rosacea; Surveys and Questionnaires; Treatment Outcome | 2017 |
Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
Topics: Administration, Topical; Adult; Aged; Animals; Anti-Inflammatory Agents; Antiparasitic Agents; Female; Humans; Ivermectin; Male; Middle Aged; Mites; Pilot Projects; Rosacea | 2017 |
The usefulness of investigating the possible underlying conditions in rosacea.
Topics: Animals; Bacillus; Gastrointestinal Microbiome; Humans; Insecticides; Ivermectin; Mite Infestations; Mites; Mutation; Rosacea; STAT1 Transcription Factor | 2018 |
Successful therapy of ocular rosacea with topical ivermectin.
Topics: Administration, Topical; Antiparasitic Agents; Face; Humans; Ivermectin; Male; Middle Aged; Rosacea; Skin Cream; Treatment Outcome | 2018 |
Misuse of veterinary wormers in self-medication of rosacea and scabies.
Topics: Administration, Cutaneous; Antiparasitic Agents; Drug Costs; Drug Misuse; Drug Resistance; Humans; Ivermectin; Norway; Online Social Networking; Rosacea; Scabies; Self Medication; Veterinary Drugs | 2019 |
Ivermectin cream (Soolantra°) and rosacea.
Topics: Humans; Ivermectin; Rosacea | 2016 |
[PATHOGENETIC FEATURES AND METHODS FOR TREATMENT OF VARIOUS FORMS OF ROSACEA].
Topics: Antiparasitic Agents; Cytokines; Erythema; Humans; Ivermectin; Ointments; Rosacea; Skin | 2019 |
Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin.
Topics: Animals; Antiparasitic Agents; Child; Eye Infections, Parasitic; Female; Humans; Ivermectin; Mite Infestations; Rosacea; Severity of Illness Index; Skin Diseases, Parasitic; Treatment Outcome | 2014 |
An emerging treatment: Topical ivermectin for papulopustular rosacea.
Topics: Administration, Cutaneous; Anti-Infective Agents; Humans; Ivermectin; Rosacea; Skin | 2015 |
Ivermectin cream (Soolantra) for rosacea.
Topics: Antiparasitic Agents; Double-Blind Method; Humans; Ivermectin; Randomized Controlled Trials as Topic; Rosacea; Skin Cream; United States; United States Food and Drug Administration | 2015 |
Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel.
Topics: Administration, Cutaneous; Animals; Antiparasitic Agents; Humans; Ivermectin; Mite Infestations; Mites; Praziquantel; Rosacea | 2015 |
Ivermectin cream for rosacea.
Topics: Adult; Clinical Trials as Topic; Dicarboxylic Acids; Drug Interactions; Humans; Ivermectin; Metronidazole; Ointments; Rosacea | 2015 |
Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.
Topics: Administration, Oral; Adult; Animals; Anti-Inflammatory Agents; Antiparasitic Agents; Blepharitis; Chronic Disease; Drug Utilization; Humans; Ivermectin; Male; Mites; Off-Label Use; Parasitic Diseases; Parasitic Diseases, Animal; Rosacea; Treatment Outcome | 2016 |
Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
Topics: Adult; Cost-Benefit Analysis; Drug Compounding; Female; Humans; Ivermectin; Male; Metronidazole; Rosacea; Skin Cream; United States | 2016 |
Facial Dermatitis and Rosacea.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Antimicrobial Cationic Peptides; Antiparasitic Agents; Brimonidine Tartrate; Cathelicidins; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Humans; Ivermectin; Rosacea | 2016 |
Treatment of rosacea with topical ivermectin cream: a series of 34 cases.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antiparasitic Agents; Female; Humans; Ivermectin; Male; Middle Aged; Rosacea; Skin Cream; Treatment Outcome; Young Adult | 2016 |
Ivermectin 1% Cream (Soolantra) for Inflammatory Lesions of Rosacea.
Topics: Administration, Cutaneous; Dermatologic Agents; Facial Dermatoses; Humans; Ivermectin; Rosacea; Skin Cream | 2016 |
Monitoring structural changes in Demodex mites under topical Ivermectin in rosacea by means of reflectance confocal microscopy: a case series.
Topics: Administration, Topical; Antiparasitic Agents; Female; Humans; Ivermectin; Male; Microscopy, Confocal; Middle Aged; Mite Infestations; Rosacea | 2017 |
EGFRI-induced papulopustular rosacea-like rash successfully treated with topical ivermectin.
Topics: Administration, Topical; Antiparasitic Agents; ErbB Receptors; Exanthema; Humans; Ivermectin; Male; Middle Aged; Mite Infestations; Remission Induction; Rosacea | 2017 |
Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases.
Topics: Administration, Oral; Administration, Topical; Adolescent; Antiparasitic Agents; Child; Child, Preschool; Facial Dermatoses; Female; Humans; Ivermectin; Male; Mouth; Rosacea | 2017 |
Rosacea: update on management and emerging therapies.
Topics: Administration, Cutaneous; Adrenergic Agents; Anti-Infective Agents; Antiparasitic Agents; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Oxymetazoline; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Sulfacetamide; Treatment Outcome | 2012 |
[Rosacea and Demodex].
Topics: Antiparasitic Agents; Erythema; Facial Dermatoses; Female; Humans; Insecticides; Ivermectin; Male; Middle Aged; Mite Infestations; Rosacea; Skin Diseases, Parasitic | 2005 |
Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Antiparasitic Agents; Drug Therapy, Combination; Humans; Insecticides; Ivermectin; Male; Mite Infestations; Permethrin; Rosacea | 2007 |
Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Dosage Forms; Humans; Insecticides; Ivermectin; Male; Mite Infestations; Permethrin; Pyrethrins; Rosacea | 1999 |